(19)
(11) EP 1 242 455 A1

(12)

(43) Date of publication:
25.09.2002 Bulletin 2002/39

(21) Application number: 00980685.2

(22) Date of filing: 22.11.2000
(51) International Patent Classification (IPC)7C07K 14/78, C07K 7/08
(86) International application number:
PCT/US0032/105
(87) International publication number:
WO 0103/8397 (31.05.2001 Gazette 2001/22)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 22.11.1999 US 447099
31.10.2000 US 702649

(71) Applicant: Abbott Laboratories
Abbott Park, IL 60064-6050 (US)

(72) Inventors:
  • HAVIV, Fortuna
    Deerfield, IL 60015 (US)
  • HENKIN, Jack
    Highland Park, IL 60035 (US)
  • BRADLEY, Michael, F.
    Wadsworth, IL 60083 (US)
  • KALVIN, Douglas, M.
    Buffalo Grove, IL 60089 (US)

(74) Representative: Modiano, Guido, Dr.-Ing. et al
Modiano, Josif, Pisanty & Staub,Baaderstrasse 3
80469 München
80469 München (DE)

   


(54) N-ALKYLATED PEPTIDES HAVING ANTIANGIOGENIC ACTIVITY